JAK selectivity: more precision less troubles.
Giulia RodaArianna Dal BuonoMarjorie Costa ArgolloSilvio DanesePublished in: Expert review of gastroenterology & hepatology (2020)
Available data on efficacy and safety of JAKi in IBD are highly encouraging and because of their selectivity, these drugs might become among the foremost options in the treatment algorithm.